MS brain scan study aims to spot progression risk early

NCT ID NCT03134716

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether special brain scans can detect signs of worsening in people with multiple sclerosis (MS). Researchers will scan 35 patients aged 40-50 who have had MS for at least five years. They are measuring brain cell activity that may signal disease progression. The goal is to find a way to predict which patients will get worse, so doctors can treat them sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a brain scan that helps doctors identify which MS patients are at risk of worsening, allowing earlier treatment.

What could go wrong

This is a small, early observational study with only 35 people. It is not testing a treatment, so it may not lead to any direct benefit for patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING - REMITTING MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Turku PET Centre

    Turku, Southwest Finland, 20520, Finland